LONDON, October 1, 2015 /PRNewswire/ --
Liver Regeneration Evidence Revealed in Scientific Study
Liver cirrhosis is a disease caused by long-term damage through infection, obesity and alcohol abuse amongst other reasons. It is now the fifth biggest killer in the UK. The only option for end-stage cirrhosis is liver transplantation. Globally more than a million people die yearly from liver disease some waiting for a suitable donor organ.
A recently published study showed the ability to repair damaged liver tissue using RecoSMA - the new technology, invented some years ago and used principally for aesthetic reasons, rejuvenation & scar removal.
Head of the group of researchers, Ivan Pikirenia M.D. PhD commented; "Previously we had already tried the action of this new technology on skin scarring and had excellent results. You see cirrhosis is a scar tissue which forms in the organ as a result of long-term damage and because it is a very similar process to skin scarring, this was the "trigger" for us to start this fascinating challenge."
Method: In the experiment the liver cirrhosis was modelled in 70 albino outbred rats by means of carbon tetrachloride. Cirrhotically changed left liver lobe was treated with the laser and the right lobe was a control. The repeated operations with the treating of the liver were carried out on the 15th, 30th, 60th days, followed by exclusion from the experiment and histological examination of the liver.
No signs of regeneration in the right liver lobe, not subjected to laser radiation, were observed. On the 60th day after double liver treating neoangiogenesis, proliferation of the bile ducts, reduction of the number of false lobules and connective tissue structures were registered compared to the right lobe of the liver.
CONCLUSION: THE NEW TECHNOLOGY CAN BE RECOMMENDED AS A "BRIDGE" THERAPY PRIOR TO LIVER TRANSPLANTATION.
Full text of the study: http://www.linline.com/en/articles/cirrhosis.html
LINLINE (http://www.linline.com) is an international manufacturer of high quality medical laser devices for aesthetic, dermatological and surgical purposes.
1. The British Liver Trust; http://www.britishlivertrust.org.uk
2. BMC Medicine; http://www.biomedcentral.com
3. Surgery News Vol. 23* No. 2 * 2015 (ISSN 2305-0047)
4. RecoSMA® is a registered trademark of Linline Medical Systems SAS, Paris, France
5. Dr. Ivan.I. Pikirenia - PhD, Associate Professor, Head of Department of Transplantation at the Belarusian Medical Academy of Postgraduate Education.
Linline Medical Systems SAS
SOURCE Linline Medical Systems SAS